Acumen Pharmaceuticals, Inc. (ABOS)
1.78
+0.09
(+5.33%)
USD |
NASDAQ |
Oct 19, 16:00
1.78
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals EPS Diluted (Quarterly) : -0.4528 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4528 |
| March 31, 2026 | -0.328 |
| December 31, 2025 | -0.415 |
| September 30, 2025 | -0.4367 |
| June 30, 2025 | -0.676 |
| March 31, 2025 | -0.4758 |
| December 31, 2024 | -0.6183 |
| September 30, 2024 | -0.4954 |
| June 30, 2024 | -0.3418 |
| March 31, 2024 | -0.2487 |
| December 31, 2023 | -0.2849 |
| September 30, 2023 | -0.2389 |
| June 30, 2023 | -0.283 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.2756 |
| December 31, 2022 | -0.3149 |
| September 30, 2022 | -0.2644 |
| June 30, 2022 | -0.2507 |
| March 31, 2022 | -0.2256 |
| December 31, 2021 | -0.2063 |
| September 30, 2021 | -0.0964 |
| June 30, 2021 | -1.516 |
| March 31, 2021 | -0.6724 |
| December 31, 2020 | -0.0188 |
| September 30, 2020 | -0.062 |
| June 30, 2020 | -0.0503 |
| March 31, 2020 | -0.0509 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 0.6557 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.72M |
| Total Expenses (Quarterly) | 32.72M |
| Enterprise Value | 43.66M |
| Earnings Yield | -91.71% |
| Normalized Earnings Yield | -91.52 |